Mutant hypoxia‑inducible factor 1α modified bone marrow mesenchymal stem cells ameliorate cerebral ischemia

Yang,Chunyu; Liu,Hua; Liu,Danping

doi:10.3892/ijmm.2014.1953

Mutant hypoxia‑inducible factor 1α modified bone marrow mesenchymal stem cells ameliorate cerebral ischemia

Authors:
- Chunyu Yang
- Hua Liu
- Danping Liu
View Affiliations

Affiliations: Department of Neurosurgery, Liaoning Medical University, Linghe, Jinzhou, Liaoning 121001, P.R. China, Department of Ophthalmology, Liaoning Medical University, Linghe, Jinzhou, Liaoning 121001, P.R. China, Department of Orthopedics, Liaoning Medical University, Linghe, Jinzhou, Liaoning 121001, P.R. China
Published online on: September 30, 2014 https://doi.org/10.3892/ijmm.2014.1953
Pages: 1622-1628

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypoxia‑inducible factor 1α (HIF1α) plays stimulatory roles in revascularization in the ischemic area of cerebral ischemia. However, the hydroxylation of proline at 564 and asparagine at 803 in the HIF1α coding sequence facilitated the degradation of HIF1α and inhibited the transcription activity of the HIF1α promoter under normoxic conditions and confined the pro‑angiogenic efficacy of HIF1α. In the present study, the HIF1α mutant containing P564A and N803A was constructed by site‑directed mutagenesis. Rat bone marrow mesenchymal stem cells (BMSCs) were infected with adenoviral particles containing HIF1α mutant at multiplicity of infection of 150. The HIF1α mRNA and protein levels under hypoxia and normoxic conditions were compared using reverse transcription‑polymerase chain reaction and western blot analysis. To explore the therapeutic effect of mutant HIF1α on the cerebral ischemia, BMSCs overexpressing mutant HIF1α were transplanted in the rat middle cerebral artery occlusion model (MCAO). The motor function and cerebral infarct size were evaluated using modified neurological severity score and triphenyltetrazolium chloride (TTC) staining within four weeks after MCAO. Vascular endothelial growth factor (VEGF) protein expression was detected by western blot analysis. Microvessel density and angiogenesis were detected by immunohistochemistry to evaluate the recovery of the brain ischemia. The HIF1α mutant containing P564A and N803A could be expressed under normoxic conditions. Transplantation of BMSCs stably expressing mutant HIF1α significantly improved motor function, reduced cerebral infarction and increased VEGF protein expression revascularization at days 7, 14 and 28 (p<0.05). Therefore, the HIF1α mutant containing P564A and N803A may be a potential target for the treatment of the cerebral ischemia.

View Figures

View References

1	Giaccia A, Siim BG and Johnson RS: HIF-1 as a target for drug development. Nat Rev Drug Discov. 2:803–811. 2003. View Article : Google Scholar : PubMed/NCBI
2	Khan TA, Sellke FW and Laham RJ: Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Ther. 10:285–291. 2003. View Article : Google Scholar : PubMed/NCBI
3	Semenza GL: Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov Today. 12:853–859. 2007. View Article : Google Scholar : PubMed/NCBI
4	Wan C, Gilbert SR, Wang Y, et al: Activation of the hypoxia-inducible factor-1α pathway accelerates bone regeneration. Proc Natl Acad Sci USA. 105:686–691. 2008.
5	Pugh CW and Ratcliffe PJ: Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 9:677–684. 2003. View Article : Google Scholar : PubMed/NCBI
6	Majmundar AJ, Wong WJ and Simon MC: Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell. 40:294–309. 2010. View Article : Google Scholar : PubMed/NCBI
7	Wang GL, Jiang BH, Rue EA and Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O₂ tension. Proc Natl Acad Sci USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
8	Fiorenzo P, Mongiardi MP, Dimitri D, et al: HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. Int J Oncol. 36:785–791. 2010.PubMed/NCBI
9	Giatromanolaki A, Fiska A, Pitsiava D, Kartalis G, Kouourakis MI and Sivridis E: Erythropoietin receptors in endometrial carcinoma as related to HIF1α and VEGF expression. In vivo. 23:699–703. 2009.PubMed/NCBI
10	Rey S and Semenza GL: Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res. 86:236–242. 2010. View Article : Google Scholar : PubMed/NCBI
11	Bruick RK and McKnight SL: A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 294:1337–1340. 2001. View Article : Google Scholar : PubMed/NCBI
12	Dang EV, Barbi J, Yang HY, et al: Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 146:772–784. 2011. View Article : Google Scholar : PubMed/NCBI
13	Evans CE, Humphries J, Mattock K, et al: Hypoxia and upregulation of hypoxia-inducible factor 1α stimulate venous thrombus recanalization. Arterioscler Thromb Vasc Biol. 30:2443–2451. 2010.
14	Kazi AA, Molitoris KH and Koos RD: Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus. Biol Reprod. 81:378–387. 2009. View Article : Google Scholar : PubMed/NCBI
15	Lando D, Peet DJ, Whelan DA, Gorman JJ and Whitelaw ML: Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 295:858–861. 2002. View Article : Google Scholar : PubMed/NCBI
16	Ralph GS, Parham S, Lee SR, et al: Identification of potential stroke targets by lentiviral vector mediated overexpression of HIF-1α and HIF-2α in a primary neuronal model of hypoxia. J Cereb Blood Flow Metab. 24:245–258. 2004.PubMed/NCBI
17	Longa EZ, Weinstein PR, Carlson S, Cummins R, et al: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
18	Liu N, Zhang Y, Fan L, et al: Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats. J Transl Med. 9:1052011. View Article : Google Scholar : PubMed/NCBI
19	Boltze J, Kowalski I, Geiger K, et al: Experimental treatment of stroke in spontaneously hypertensive rats by CD34⁺ and CD34⁻ cord blood cells. Ger Med Sci. 3:Doc092005.PubMed/NCBI
20	Neumann-Haefelin T, Kastrup A, de Crespigny A, Yenari MA, Ringer T, Sun GH and Moseley ME: Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation. Stroke. 31:1965–1972. 2000. View Article : Google Scholar
21	Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
22	Mustafa AK, Ahmad AS, Zeynalov E, et al: Serine racemase deletion protects against cerebral ischemia and excitotoxicity. J Neurosci. 30:1413–1416. 2010. View Article : Google Scholar : PubMed/NCBI
23	Ruiz-Crespo S, Trejo-Gabriel-Galán JM and Coma-del-Corral MJ: Localizing coordinates of cerebral ischemic tissue without the need of staining in a rat model of focal cerebral infarct. Metab Brain Dis. 28:21–24. 2013. View Article : Google Scholar : PubMed/NCBI
24	Yu J, Zhu H, Ko D and Kindy MS: Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse. Brain Res. 1238:143–153. 2008.PubMed/NCBI
25	Elson DA, Thurston G, Huang LE, Ginzinger DG, McDonald DM, Johnson RS and Arbeit JM: Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α. Genes Dev. 15:2520–2532. 2001.
26	Menge T, Zhao Y, Zhao J, et al: Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury. Sci Transl Med. 4:161ra1502012. View Article : Google Scholar : PubMed/NCBI
27	Pati S, Khakoo AY, Zhao J, et al: Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling. Stem Cells Dev. 20:89–101. 2011.PubMed/NCBI
28	Warach S and Latour LL: Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke. 35:2659–2661. 2004. View Article : Google Scholar
29	Zacharek A, Chen J, Cui X, et al: Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab. 27:1684–1691. 2007. View Article : Google Scholar : PubMed/NCBI